We work at the interface of nanoscience, microfluidics and molecular biology
to pioneer novel drug delivery systems

We design nanoparticles for applications in drug delivery. To ensure clinical translation of the novel therapies designed in the lab, we develop humanized organ-on-a-chip models for preclinical evaluation of nanoparticles. The vision of this research program is to bridge the gap between fundamental science and practice, with a commitment to serve vulnerable populations.